Cabaletta Bio Inc

NASDAQ:CABA   10:57:22 AM EDT
1.25
-0.03 (-2.34%)
Earnings Announcements

Cabaletta Bio Reports Q4, Full Year 2021 Financial Results

Published: 03/17/2022 11:14 GMT
Cabaletta Bio Inc (CABA) - Cabaletta Bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update.
Cabaletta Bio Inc - Ended 2021 With $122.2 Million in Cash on Hand to Fund Operations Through 3q 2023.
Cabaletta Bio Inc Qtrly Net Loss per Voting and Non-voting Share, Basic and Diluted $0.49.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.53

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.49

More details on our Analysts Page.